Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer

Baselga, J Tripathy, D Mendelsohn, J Baughman, S Benz, CC Dantis, L Sklarin, NT Seidman, AD Hudis, CA Moore, J Rosen, PP Twaddell, T Henderson, IC Norton, L

J. Baselga et al., Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer, SEMIN ONCOL, 26(4), 1999, pp. 78-83

35

Oncology,"Onconogenesis & Cancer Research

SEMINARS IN ONCOLOGY

00937754 → ACNP

26

4

1999

12

78 - 83

ISI

0093-7754(199908)26:4<78:PISOWI>2.0.ZU;2-D